| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/29/2005 | WO2005089229A2 Vpac1 selective antagonists and their pharmacological methods of use |
| 09/29/2005 | WO2005089106A2 Degradable nanoparticles |
| 09/29/2005 | WO2005089080A2 Method and kit for screening, pharmaceutical compositions and method for treatment of autoimmune disorders |
| 09/29/2005 | WO2005089070A2 Thrombin derivatives and medicinal composition containing the same |
| 09/29/2005 | WO2005089047A2 Glycosylated glucocerebrosidase expression in fungal hosts |
| 09/29/2005 | WO2005080559B1 Fungall cell wall degrading enzyme |
| 09/29/2005 | WO2005079508A3 Method and composition for angiogenesis inhibition |
| 09/29/2005 | WO2005078076A3 Tpl2 and its expression |
| 09/29/2005 | WO2005074967A3 Progastrin derived peptides |
| 09/29/2005 | WO2005072765A3 An efficient method to synthesize benzyl group-protected alpha-pentagalloylglucose (α-pgg) and its analogues |
| 09/29/2005 | WO2005072295A3 Methods for reducing oxidative damage |
| 09/29/2005 | WO2005067900A3 Azabenzofuran substituted thioureas as inhibitors of viral replication |
| 09/29/2005 | WO2005063807A3 Treatment of coronary or peripheral ischemia |
| 09/29/2005 | WO2005063801A3 Method for decreasing the contact between hepta-repeat region s of the corona-virus spike proteins and use thereof |
| 09/29/2005 | WO2005061002A3 Composition and methods for modulating cns activity |
| 09/29/2005 | WO2005056752A3 Methods and compositions for delivering polynucleotides |
| 09/29/2005 | WO2005054440A3 A biomimetic composition reinforced by a polyelectrolytic complex of hyaluronic acid and chitosan |
| 09/29/2005 | WO2005046732A3 Methods and compositions for the inhibition of hiv-1 replication |
| 09/29/2005 | WO2005039642A9 Dna delivery with gemini cationic surfactants |
| 09/29/2005 | WO2005030196A3 Methods of treating autoimmune diseases using il-21 |
| 09/29/2005 | WO2005029066A3 Diagnostic markers and pharmacological targets in heart failure and related reagents and methods of use thereof |
| 09/29/2005 | WO2005028516A3 Albumin-binding derivatives of therapeutic peptides |
| 09/29/2005 | WO2005012329A3 Kinase and phosphatase assays |
| 09/29/2005 | WO2005011584A3 Decorin proteoglycan inhibitor of fibrinogen blood clotting |
| 09/29/2005 | WO2005007820A3 Activated protein c variants with normal cytoprotective activity but reduced anticoagulant activity |
| 09/29/2005 | WO2005003336A3 Newly identified cholinephosphotransferases and ethanolaminephosphotransferases |
| 09/29/2005 | WO2005000244A3 Methods and compositions for treating rheumatoid arthritis |
| 09/29/2005 | WO2004113552A3 Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
| 09/29/2005 | WO2004103315A3 Treatment of ophthalmic infections using antimicrobial peptides |
| 09/29/2005 | WO2004103292A3 Process for manufacture of nematode-extracted anticoagulant protein (nap) |
| 09/29/2005 | WO2004103149B1 Genes encoding single chain human leukocyte antigen e (hla-e) proteins to prevent natural killer cell-mediated cytotoxicity |
| 09/29/2005 | WO2004099410A3 Compound and method for regulating plasminogen activation and cell migration |
| 09/29/2005 | WO2004076632A3 Methods of screening for trpm5 modulators |
| 09/29/2005 | WO2004073609A3 Posh associated kinases and related methods |
| 09/29/2005 | WO2004056314B1 Compositions and methods for enhanced mucosal delivery of y2 receptor-binding peptides and methods for treating and preventing obesity |
| 09/29/2005 | WO2004043385A3 Methods and compositions for prostate epithelial cell differentiation |
| 09/29/2005 | WO2004042011A3 Promotion of peroxisomal catalase function in cells |
| 09/29/2005 | WO2004031365A3 Sulfatases and methods of use thereof |
| 09/29/2005 | WO2004014314A3 Methods and compositions concerning poxviruses and cancer |
| 09/29/2005 | WO2004012662A3 Improved treatment of cancer with glutamine |
| 09/29/2005 | WO2003076469A9 Antibodies derived rom anti ed-b l19 and targeting tumor vasculature |
| 09/29/2005 | WO2003074057A8 Anti-infective agents and/or immunomodulators used for preventive therapy following an acute cerebrovascular accident |
| 09/29/2005 | US20050216962 Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species |
| 09/29/2005 | US20050216961 Cancer associated protein kinases and their uses |
| 09/29/2005 | US20050216960 Using tumor necrosis factor related apoptosis inducing ligand receptor (TRAIL-R) to identify modulators of dendritic cell immune response |
| 09/29/2005 | US20050216959 Using biobolistic electric discharge particle acceleration to transfer gold coated beads into cells; improving heterologous gene transfer and expression |
| 09/29/2005 | US20050215766 Allergen from mugwort pollen |
| 09/29/2005 | US20050215593 Kaposi's sarcoma; Crohn's disease |
| 09/29/2005 | US20050215573 Novel inhibitors of glutaminyl cyclase |
| 09/29/2005 | US20050215565 Using sulfonamides such as N-[N-(3-pyridinesulfonyl)-L-3,3-dimethyl-4-thiaprolyl]-O-[1-methylpiperazin-4-ylcarbonyl]-L-tyrosine isopropyl ester optionally with immunoglobulins, steroids, antiinflammatory agents |
| 09/29/2005 | US20050215541 Alzheimer's disease; benzodiazapines |
| 09/29/2005 | US20050215528 Gnrh agonist combination drugs |
| 09/29/2005 | US20050215520 Complex of organic medicines and beta-cyclodextrin derivatives and its preparing process |
| 09/29/2005 | US20050215509 Method for inhibiting jnk-1 kinase activity by SCCA |
| 09/29/2005 | US20050215506 Antisense nucleotide sequences for inhibiting the expression of tyrosinase; control melanin biosynthetic pathway; treating pigment disorder of eyes, hair, and skin, and melanoma |
| 09/29/2005 | US20050215503 HIF oligonucleotide decoy molecules |
| 09/29/2005 | US20050215502 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 09/29/2005 | US20050215499 Lipoproteins as nucleic acid vectors |
| 09/29/2005 | US20050215498 Method for the protection of endothelial and epithclial cells during chemotherapy |
| 09/29/2005 | US20050215497 Treating prostate cancer by administering double stranded oligonucleotide having two complementary oligonucleotide sequences forming a hybrid; each sequence has at one 3' or 5' end 1-5 unpaired nucleotides forming single-strand ends extending beyond the hybrid |
| 09/29/2005 | US20050215486 Peptidomimetic compounds, useful as antiviral agents |
| 09/29/2005 | US20050215484 Di-, tri-, and tetra-peptides having antiangiogenic activity |
| 09/29/2005 | US20050215483 Peptide inhibitors of protein kinase c |
| 09/29/2005 | US20050215482 Modulating cell adhesion, cancer cell adhesion, cancer cell invasion, cancer metastasis, bone turnover and remodeling, VEGF synthesis, TGF-beta synthesis |
| 09/29/2005 | US20050215481 Antimicrobial peptide, its analogs and antimicrobial composition comprising them |
| 09/29/2005 | US20050215480 Alpha conotoxin peptides with analgesic properties |
| 09/29/2005 | US20050215479 Diagnostic indicator of thymic function |
| 09/29/2005 | US20050215478 Amino acid sequences capable of facilitating penetration across a biological barrier |
| 09/29/2005 | US20050215477 Treating agonist disorderssuch asd diabetes, obesity, heart dysfunctions, AIDS-related wasting, and kidney, neurological, whole body growth disorders by administering a crystal of an insulin-like growth factor-1 that diffracts x-ray radiation to produce a three-dimensional diffraction pattern |
| 09/29/2005 | US20050215476 Amidated parathyroid hormone fragments and uses thereof |
| 09/29/2005 | US20050215475 Transmucosal delivery of peptides and proteins |
| 09/29/2005 | US20050215474 inducing a specific immune response to DNA vaccines; as an adjuvant, immunostimulants |
| 09/29/2005 | US20050215473 Prophylactic and therapeutic uses of FGF-20 in radiation protection |
| 09/29/2005 | US20050215472 PSMA formulations and uses thereof |
| 09/29/2005 | US20050215471 Compositions of bacteria and alpha-lactalbumin and uses thereof |
| 09/29/2005 | US20050215470 peptides and/or conjugated peptides may be used as therapeutics or prophylactics for the treatment of diseases mediated by B1 activation, including inflammation and chronic pain states of inflammatory and neuropathic origin, septic shock, arthritis, osteoarthritis, angina, asthma, allergic rhinitis |
| 09/29/2005 | US20050215469 Reducing food intake; obesity; dietetics |
| 09/29/2005 | US20050215468 Metal-binding compounds and uses therefor |
| 09/29/2005 | US20050215467 Multimeric Apo A-I agonist compounds |
| 09/29/2005 | US20050215466 Administering a plasminogen activator inhibitor type 1 isoform lacking a reactive center loop and containing a complete heparin-binding domain or lacking at least a portion of a heparin-binding domain through blocking release of VEGF from a VEGF-heparin complex |
| 09/29/2005 | US20050215465 Methods of inducing IL-10 production |
| 09/29/2005 | US20050215464 Binding agents for cd44 glycoproteins and methods of use |
| 09/29/2005 | US20050214943 Transcription factors; nuclear localization peptides; signal sequences; NF-kappaB/Rel proteins; modulating expression of a gene |
| 09/29/2005 | US20050214919 Novel lipase genes |
| 09/29/2005 | US20050214910 Chordin-like molecules and uses thereof |
| 09/29/2005 | US20050214903 O-superfamily conotoxin peptides |
| 09/29/2005 | US20050214893 Identifying modulators for prevention and treatment of cell proliferative disorders; antitumor agents |
| 09/29/2005 | US20050214886 Using intracellular domain of tumor necrosis factor as screening tool in detection of modulators for treatment of inflammation, sepsis, rheumatic and eating disorders |
| 09/29/2005 | US20050214883 Novel alanine transaminase enzyme and methods of use |
| 09/29/2005 | US20050214871 Using CD163 (Cluster of Differentiation 163) protein as tool in identifying modulator for prevention and treatment of cardiovascular, autoimmune, nervous system and inflammatory disorders |
| 09/29/2005 | US20050214869 Molecular interactions in hematopoietic cells |
| 09/29/2005 | US20050214859 Hepatocyte growth factor (HGF) receptor complex for identifying modulator for prevention and treatment of cell proliferative disorders |
| 09/29/2005 | US20050214856 Nucleotide sequences coding bone morphogenic protein for identifying modulators for treatment of bone diseases |
| 09/29/2005 | US20050214853 Methods of screening agents, conjugates or conjugate moieties for transport by a PEPT2 transporter |
| 09/29/2005 | US20050214848 Reagents and methods useful for detecting diseases of the breast |
| 09/29/2005 | US20050214846 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/29/2005 | US20050214845 Small and intermediate conductance, calcium-activated potassium channels and uses thereof |
| 09/29/2005 | US20050214844 Nucleotide sequences coding translocation protein for use in identifying modulators for prevention and treatment of cell proliferative ,inflammatory and autoimmune disorders |
| 09/29/2005 | US20050214837 Antibody specific for mutant presenilin 1 and method of use thereof |
| 09/29/2005 | US20050214835 Diagnosis and treatment of myocardial failure |